David Piacquad - Net Worth and Insider Trading

David Piacquad Net Worth

The estimated net worth of David Piacquad is at least $11 Million dollars as of 2024-04-12. David Piacquad is the SVP, Business Development of Amgen Inc and owns about 39,700 shares of Amgen Inc (AMGN) stock worth over $11 Million. Details can be seen in David Piacquad's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Piacquad has not made any transactions after 2020-02-06 and currently still holds the listed stock(s).

Transaction Summary of David Piacquad

To

David Piacquad Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Piacquad owns 2 companies in total, including Amgen Inc () , and Neumora Therapeutics Inc () .

Click here to see the complete history of David Piacquad’s form 4 insider trades.

Insider Ownership Summary of David Piacquad

Ticker Comapny Transaction Date Type of Owner
Amgen Inc 2020-02-06 SVP & Business Development
Neumora Therapeutics Inc 2023-09-14 director

David Piacquad Latest Holdings Summary

David Piacquad currently owns a total of 1 stock. David Piacquad owns 39,700 shares of Amgen Inc (AMGN) as of February 6, 2020, with a value of $11 Million.

Latest Holdings of David Piacquad

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2020-02-06 39,700 267.30 10,611,810

Holding Weightings of David Piacquad


David Piacquad Form 4 Trading Tracker

According to the SEC Form 4 filings, David Piacquad has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 9,264 shares on February 6, 2020, which brought David Piacquad around $2 Million.

Insider Trading History of David Piacquad

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Piacquad Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Piacquad Ownership Network

Ownership Network List of David Piacquad

No Data

Ownership Network Relation of David Piacquad


David Piacquad Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

David Piacquad is the SVP & Business Development of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc () Insider Trades Summary

Over the past 18 months, David Piacquad made no insider transaction in Amgen Inc (). Other recent insider transactions involving Amgen Inc () include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.

Amgen Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

David Piacquad Mailing Address

Above is the net worth, insider trading, and ownership report for David Piacquad. You might contact David Piacquad via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Discussions on David Piacquad

No discussions yet.